-
Something wrong with this record ?
Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity
L. Petruzelkova, K. Pickova, Z. Sumnik, J. Soupal, B. Obermannova,
Language English Country United States
Document type Comparative Study, Journal Article, Observational Study
PubMed
28520532
DOI
10.1089/dia.2016.0459
Knihovny.cz E-resources
- MeSH
- Algorithms MeSH
- Monitoring, Ambulatory * adverse effects MeSH
- Child Behavior * MeSH
- Activities of Daily Living MeSH
- Exercise * MeSH
- Diabetes Mellitus, Type 1 blood diet therapy drug therapy metabolism MeSH
- Diet, Diabetic adverse effects MeSH
- Dietary Carbohydrates adverse effects metabolism MeSH
- Child MeSH
- Hyperglycemia prevention & control MeSH
- Hypoglycemia epidemiology etiology prevention & control MeSH
- Incidence MeSH
- Insulin Infusion Systems * adverse effects MeSH
- Combined Modality Therapy adverse effects MeSH
- Blood Glucose analysis MeSH
- Humans MeSH
- Adolescent MeSH
- Sports * MeSH
- Materials Testing MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Observational Study MeSH
- Comparative Study MeSH
- Geographicals
- Czech Republic epidemiology MeSH
BACKGROUND: The prevention of postexercise nocturnal hypoglycemia after prolonged physical activity using sensor-augmented pump (SAP) therapy with predictive low-glucose management (PLGM) has not been well studied. We conducted a study at a pediatric diabetes camp to determine whether a SAP with PLGM reduces the frequency of nocturnal hypoglycemia after prolonged physical activity more effectively than a SAP with a carbohydrate intake algorithm. METHODS: During a 1-week sport camp, 20 children (aged 10-13 years) with type 1 diabetes (T1D) managed by SAP therapy either with (n = 7) or without PLGM (n = 13) were studied. The hypoglycemia management strategy and the continuous glucose monitoring (CGM)/PLGM settings were standardized. The incidence, severity, and duration of hypoglycemia and carbohydrate intake were documented and compared. RESULTS: The PLGM system was activated on 78% of all nights (once per night on average). No difference was found between the SAP and PLGM groups in the mean overnight glucose curve or mean morning glucose (7.8 ± 2 mmol/L vs. 7.4 ± 3 mmol/L). There was no difference in the frequency and severity of hypoglycemia. However, the SAP group consumed significantly more carbohydrates to prevent and treat hypoglycemia than those in the PLGM group; the values were 10 ± 2 and 1 ± 2 gS (P < 0.0001) in the SAP and PLGM groups, respectively. Moreover, the SAP group spent a significantly longer time in hypoglycemia (64 ± 2 min vs. 38 ± 2 min, P < 0.05). We observed a difference in the time distribution of nocturnal hypoglycemia (10 to 12 p.m. in the PLGM group and 3 to 7 a.m. in the SAP group, P < 0.05). CONCLUSION: With PLGM system, euglycemia after prolonged physical activity was largely maintained with a minimal carbohydrate intake.
3rd Department of Internal Medicine 1st Faculty of Medicine Charles University Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010554
- 003
- CZ-PrNML
- 005
- 20180419085954.0
- 007
- ta
- 008
- 180404s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1089/dia.2016.0459 $2 doi
- 035 __
- $a (PubMed)28520532
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Petruzelkova, Lenka $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
- 245 10
- $a Effectiveness of SmartGuard Technology in the Prevention of Nocturnal Hypoglycemia After Prolonged Physical Activity / $c L. Petruzelkova, K. Pickova, Z. Sumnik, J. Soupal, B. Obermannova,
- 520 9_
- $a BACKGROUND: The prevention of postexercise nocturnal hypoglycemia after prolonged physical activity using sensor-augmented pump (SAP) therapy with predictive low-glucose management (PLGM) has not been well studied. We conducted a study at a pediatric diabetes camp to determine whether a SAP with PLGM reduces the frequency of nocturnal hypoglycemia after prolonged physical activity more effectively than a SAP with a carbohydrate intake algorithm. METHODS: During a 1-week sport camp, 20 children (aged 10-13 years) with type 1 diabetes (T1D) managed by SAP therapy either with (n = 7) or without PLGM (n = 13) were studied. The hypoglycemia management strategy and the continuous glucose monitoring (CGM)/PLGM settings were standardized. The incidence, severity, and duration of hypoglycemia and carbohydrate intake were documented and compared. RESULTS: The PLGM system was activated on 78% of all nights (once per night on average). No difference was found between the SAP and PLGM groups in the mean overnight glucose curve or mean morning glucose (7.8 ± 2 mmol/L vs. 7.4 ± 3 mmol/L). There was no difference in the frequency and severity of hypoglycemia. However, the SAP group consumed significantly more carbohydrates to prevent and treat hypoglycemia than those in the PLGM group; the values were 10 ± 2 and 1 ± 2 gS (P < 0.0001) in the SAP and PLGM groups, respectively. Moreover, the SAP group spent a significantly longer time in hypoglycemia (64 ± 2 min vs. 38 ± 2 min, P < 0.05). We observed a difference in the time distribution of nocturnal hypoglycemia (10 to 12 p.m. in the PLGM group and 3 to 7 a.m. in the SAP group, P < 0.05). CONCLUSION: With PLGM system, euglycemia after prolonged physical activity was largely maintained with a minimal carbohydrate intake.
- 650 _2
- $a činnosti denního života $7 D000203
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a algoritmy $7 D000465
- 650 _2
- $a krevní glukóza $x analýza $7 D001786
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a chování dětí $7 D002652
- 650 _2
- $a kombinovaná terapie $x škodlivé účinky $7 D003131
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a diabetes mellitus 1. typu $x krev $x dietoterapie $x farmakoterapie $x metabolismus $7 D003922
- 650 _2
- $a diabetická dieta $x škodlivé účinky $7 D003927
- 650 _2
- $a dietní sacharidy $x škodlivé účinky $x metabolismus $7 D004040
- 650 12
- $a cvičení $7 D015444
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperglykemie $x prevence a kontrola $7 D006943
- 650 _2
- $a hypoglykemie $x epidemiologie $x etiologie $x prevence a kontrola $7 D007003
- 650 _2
- $a incidence $7 D015994
- 650 12
- $a inzulinové infuzní systémy $x škodlivé účinky $7 D007332
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a testování materiálů $7 D008422
- 650 12
- $a ambulantní monitorování $x škodlivé účinky $7 D018670
- 650 12
- $a sporty $7 D013177
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Pickova, Klara $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
- 700 1_
- $a Sumnik, Zdenek $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
- 700 1_
- $a Soupal, Jan $u 2 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague , Czech Republic .
- 700 1_
- $a Obermannova, Barbora $u 1 Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague , Czech Republic .
- 773 0_
- $w MED00173679 $t Diabetes technology & therapeutics $x 1557-8593 $g Roč. 19, č. 5 (2017), s. 299-304
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28520532 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180419090055 $b ABA008
- 999 __
- $a ok $b bmc $g 1288039 $s 1007366
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 19 $c 5 $d 299-304 $i 1557-8593 $m Diabetes technology & therapeutics $n Diabetes Technol Ther $x MED00173679
- LZP __
- $a Pubmed-20180404